Live Breaking News & Updates on Head of the department medical oncology

Stay informed with the latest breaking news from Head of the department medical oncology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Head of the department medical oncology and stay connected to the pulse of your community

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated Approval in First-Line Metastatic Uveal Melanoma

Confirmed overall response rate of 45%, disease control rate of 90% and median PFS of ~7 months in 20 evaluable First-Line MUM patientsBased on FDA meeting, initiating Phase 2/3 registrational... | April 23, 2023

Russia , Monash , South-australia , Australia , Ukraine , Sydney , New-south-wales , Melbourne , Victoria , Neoadjuvant-po , Meredith-mckean , Anthony-joshua

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated Approval in First-Line Metas

IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated Approval in First-Line Metas
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Monash , South-australia , Australia , Ukraine , Russia , Sydney , New-south-wales , Melbourne , Victoria , Yujiros-hata , Anthony-joshua , Mark-shackleton

Randomized Trial for High-risk Cutaneous Squamous Cell Carcinoma Patients Treated With Adjuvant Cemiplimab

High-risk patients with cutaneous squamous cell carcinoma (CSCC) have an unmet need with regard to systemic adjuvant medical options after the gold standard of surgery and radiotherapy to reduce the risk of locoregional advanced disease or distant metastases. The safety profile of adjuvant cemiplimab is favorable. Professor Danny Rischin (Director of the Division of Cancer

Australia , United-states , Melbourne , Victoria , Chicago , Illinois , American , Danny-rischin , Neil-gross , Division-of-cancer-medicine , Head-of-the-department-medical-oncology , American-society-of-clinical-oncology

ESMO 2021: Systemic Treatments and Novel Approaches

ESMO 2021: Systemic Treatments and Novel Approaches
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

Lugano , Ticino , Switzerland , Toronto , Ontario , Canada , Bellinzona , Christopher-jd-wallis , Silke-gillessen , University-of-toronto , Oncology-institute-of-southern-switzerland , Head-of-the-department-medical-oncology

Majority of children with cancer recover from COVID without developing complications

Majority of children with cancer recover from COVID without developing complications
At a time when parents are worried over the possibility of children being adversely infected by the third wave of COVID-19, here is a positive development.
STAFF REPORTER
GUWAHATI: At a time when parents are worried over the possibility of children being adversely infected by the third wave of COVID-19, here is a positive development. Doctors are claiming that the majority of children suffering from cancer have recovered from COVID-19 without developing complications.
Altogether 34 children at the Dr B Borooah Cancer Institute (BBCI) have been infected with SARS-CoV-2 (the virus that causes COVID-19) so far this year. Till Monday (July 5, 2021), as many as 30 children have recovered from COVID-19 without developing complications. Even though four children are yet to test COVID negative, they have not developed any complications.

Gauhati , Assam , India , Guwahati , New-delhi , Delhi , Munlima-hazarika , Gauhati-medical-college-hospital , Head-of-the-department-medical-oncology , Drb-borooah-cancer-institute , India-institute-of-medical-sciences , World-health-organisation

GSRGT 2020: The International Germ Cell Cancer Collaborative Group (IGCCCG) Update

GSRGT 2020: The International Germ Cell Cancer Collaborative Group (IGCCCG) Update
(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12
th focused on testis cancer. In this session, the organizers convened a “Clinical Trials Corner” in which Dr. Silke Gillessen presented an update from the International Germ Cell Cancer Collaborative Group (IGCCCG).
As clinicians treating germ cell tumors will know, the International Germ Cell Cancer Collaborative Group published a consensus-based prognostic classification of germ cell tumors in 1997. This stratification has been widely used since that time for both clinical care and trial design. Notably, it was based on treatments delivered between 1975 and 1990, in which not all patients received cisplatin-based regimes which would now be considered standard of care.

Tennessee , United-states , Switzerland , Vanderbilt-university , Christopher-jd-wallis , Silke-gillessen , Oncology-institute-of-southern-switzerland , Global-society-of-rare-genitourinary-tumors , Head-of-the-department-medical-oncology , Vanderbilt-university-medical-center , Twitter , International-germ-cell-cancer-collaborative-group